DR. BELINDA MAPLES M.D. NPI 1245223684

NPI Details

DR. Belinda Maples, M.D. is a family medicine in Athens, AL with 31 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Belinda Maples, M.D. NPI is 1245223684. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:1995

The provider's business location address is:

101 FITNESS WAY
SUITE 1200
ATHENS, AL
ZIP 35611-492
Phone: (256) 232-0636
Fax: (256) 232-1058

The NPI 1245223684 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 01D1018618 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Urinalysis, manual test (HCPCS:81002)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Colonoscopy (HCPCS:NAN13)
• Upper gastrointestinal (GI) endoscopy for acid reflux (HCPCS:NAN12)
• Melanoma (skin cancer) excision (HCPCS:NAN03)
• Leg revascularization (restoring blood flow) (HCPCS:NAN01)

The enumeration date for this NPI number is 8/30/2005 and was last updated on 5/7/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.